In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Springworks Therapeutics (SWTX – Research ...
Craig-Hallum analyst Anthony Stoss assigned a Buy rating to the stock today. The company’s shares closed yesterday at $87.98. According ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback